{
    "clinical_study": {
        "@rank": "36626", 
        "acronym": "FIM", 
        "arm_group": {
            "arm_group_label": "Carotid body excision", 
            "arm_group_type": "Experimental", 
            "description": "Patients undergoing unilateral or bilateral removal of carotid body."
        }, 
        "brief_summary": {
            "textblock": "The aim of the study is to determine safety, tolerability and feasibility of unilateral and\n      bilateral carotid body excision in patients with systolic heart failure and peripheral\n      chemoreceptor hypersensitivity."
        }, 
        "brief_title": "Surgical Removal of Carotid Body in Patients With Systolic Heart Failure", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Systolic Heart Failure", 
            "Peripheral Chemoreceptor Hypersensitivity"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Hypersensitivity", 
                "Heart Failure, Systolic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of heart failure class II-III according to NYHA within at least 6 months\n             prior to inclusion\n\n          -  Stable clinical state within at least 4 weeks prior to inclusion\n\n          -  Subject >= 18 years old\n\n          -  Left ventricular ejection fraction \u2264 45% evaluated by transthoracic echocardiography\n             (Simpson's method)\n\n          -  Carotid body present in computer cervical angiotomography\n\n          -  History of exacerbated peripheral chemoreceptor sensitivity determined as\n             >0.6L/min/%SpO2\n\n          -  Able and willing to give written informed consent\n\n        Exclusion Criteria:\n\n          -  Unstable angina pectoris, coronary attack, coronary revascularization, exacerbation\n             of heart-failure requiring hospitalization, clinically significant infection, surgery\n             under general anesthesia within 3 months prior to inclusion\n\n          -  History of stroke, transient ischemic attack (TIA), or clinically significant chronic\n             neurological disorder\n\n          -  History of heart transplant\n\n          -  Pregnancy or anticipation of pregnancy\n\n          -  Hemodialysis or peritoneal dialysis patients\n\n          -  Obstructive carotid atherosclerotic disease with >50% stenosis\n\n          -  Severe sleep apnea syndrome diagnosed in PSG\n\n          -  COPD stage III and IV according to GOLD 2007\n\n          -  Unable to perform the spiroergometric assessment\n\n          -  Any significant anomaly in additional investigation which may increase the risk of\n             study procedure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01653821", 
            "org_study_id": "FIM-WROCPL-CORIDEA"
        }, 
        "intervention": {
            "arm_group_label": "Carotid body excision", 
            "intervention_name": "Carotid body excision", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "carotid body", 
            "heart failure", 
            "chemoreceptor", 
            "hypersensitivity"
        ], 
        "lastchanged_date": "November 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Wroclaw", 
                    "country": "Poland", 
                    "zip": "50-981"
                }, 
                "name": "Centrum Choro\u0301b Serca - Klinika Kardiologii, 4. Wojskowy Szpital Kliniczny"
            }
        }, 
        "location_countries": {
            "country": "Poland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Surgical Removal of Carotid Body in Patients With Systolic Heart Failure.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Poland: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Ventilatory response to hypoxia using transient inhalation of nitrogen.", 
            "measure": "Peripheral chemosensitivity", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01653821"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Noblewell", 
        "sponsors": {
            "collaborator": {
                "agency": "Cibiem, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Noblewell", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}